Dana Jean la Haie
Psychiatry · Phoenix, AZNPI 1669679288
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$762
- Otsuka America Pharmaceutical, Inc.$744
- Sunovion Pharmaceuticals Inc.$725
- Corium, LLC$466
- Ironshore Pharmaceuticals Inc.$443
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$393
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,33899%
- Education$411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $762 |
| Otsuka America Pharmaceutical, Inc. | 42 | $744 |
| Sunovion Pharmaceuticals Inc. | 37 | $725 |
| Corium, LLC | 30 | $466 |
| Ironshore Pharmaceuticals Inc. | 25 | $443 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $393 |
| Johnson & Johnson | 18 | $375 |
| Tris Pharma Inc | 22 | $347 |
| Lundbeck LLC | 18 | $300 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $299 |
| Alkermes, Inc. | 10 | $236 |
| Eisai Inc. | 10 | $188 |
| Neurocrine Biosciences, Inc. | 8 | $149 |
| Vanda Pharmaceuticals Inc. | 6 | $137 |
| Supernus Pharmaceuticals, Inc. | 6 | $130 |
| Almatica Pharma LLC | 6 | $129 |
| Bausch Health US, LLC | 7 | $123 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Neos Therapeutics, LP | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $72 |
| Jazz Pharmaceuticals Inc. | 2 | $48 |
| Shire North American Group Inc | 4 | $48 |
| Alfasigma USA, Inc. | 3 | $44 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Merck | 1 | $15 |
How this compares
$6,379 in reported general payments places this provider in the 90th percentile of 573 psychiatry providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 12 | $175 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $129 | $17512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 573 psychiatry providers in Arizona.
Other psychiatry in Phoenix
- Jason CaplanPhoenix$999K
- Thomas GazdaPhoenix$714K
- Monica BenavidezPhoenix$435K
- Eric ReimanPhoenix$157K
- Padma AkingPhoenix$44K
- Ahmed ElmaadawiPhoenix$32K
- Amnon KahanePhoenix$18K
- Aaron ClayPhoenix$14K
- Joel ParkerPhoenix$11K
- Ivan EngelPhoenix$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.